Latest news in Investment research

Higher risk tolerance leads to creative options

Technology diamonds in the rough

Healthy long-term prognosis for biotech sector

Use a strip bond-based system to invest fearlessly

Once again, the steady tortoise wins the race

Time is right to buy options on the Canadian banks

Portfolio options are varied for these investors

These biotechs pronounced among the healthiest

Bond rate activity could signal economic downturn

Bank stocks are losing their allure

Junior market honours top firms

Earnings and dividend growth point to winners

ME offers covered call writers a useful tool

Generic drug market set to boom

Investors begin to run to the bond market for cover

Three-year cycles point to rise and fall of industry groups

New generation of silver miners hits the right vein

Construct a portfolio to enhance its synergies

Outlook improves but challenges persist

Retiree spending habits re-evaluated

Return on equity a powerful tool

Scripophilic sleuths uncover the value in old bonds

Japanese bull awakens. But is it sustainable?

Drugmakers’ prospects healthy over the long term

Clarington banks on advisors, new products